Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 687-893-6 | CAS number: 1150560-54-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 7th August 2018 to 22nd November 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-5-iodo-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- EC Number:
- 687-893-6
- Cas Number:
- 1150560-54-5
- Molecular formula:
- C13H9F4IN2O2
- IUPAC Name:
- 1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-5-iodo-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on species / strain selection:
- Grade SPF
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Beijing Vital River Laboratory Animal Technology Ltd.
- Age at study initiation: (P) - 56-62 days
- Weight at study initiation: (P) Males: 290-340g; Females: 195-235g;
- Housing: Suspension stainless steel cages on cage racks, 2 rats per cage at most, with corn cob bedding. During mating, the rats were housed in mating cages. After mating, females were housed in plastic cages, with a bedding of wood shaving.
- Diet: Sterilised growth and breeding feed from Beijing Keao Xiele Feed Co. ad libitum
- Water: Drinking water ad libitum
- Acclimation period: 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-25
- Humidity (%): 40-70
- Photoperiod: (12 hrs dark / hrs light 12)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test item was weighed and placed in a jar, and corn oil added to give the required concentration. The jars were then mixed with the magnetic stirring apparatus for 1 minute. The test item was prepared daily.
VEHICLE
- Amount of vehicle: 5ml/kg bw - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: 2 weeks
- Proof of pregnancy: vaginal plug / sperm in vaginal smear referred to as day 0 of pregnancy (GD0)
- After successful mating each pregnant female was caged in a plastic cage - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 2 weeks of mating;
Up to day before scheduled kill, (except during childbirth)
- Frequency of treatment:
- Once daily in the morning, 7 days per week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Remarks:
- Both male and female
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Remarks:
- Both male and female
- Dose / conc.:
- 800 mg/kg bw/day (nominal)
- Remarks:
- Female highest dose
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Remarks:
- Male highest dose
- No. of animals per sex per dose:
- 14
- Control animals:
- yes, concurrent vehicle
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily
- Cage side observations checked included: appearance, fur, activity, reaction, breathing, posture, excrement and urine.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Once per week in conjunction with weighing
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION: The food ration was added weekly and food intake weighed the following day.
PARTURITION: Yes
- From GD21, observations made twice daily (morning and afternoon). Any difficulties were recorded. - Litter observations:
PARAMETERS EXAMINED
The following parameters were examined in F1offspring (PND0):
stillbirths, live births, postnatal mortality, presence of grossly malformed pups, grossly puny pups.
PND4: signs of behavioural abnormalities
GROSS EXAMINATION OF DEAD PUPS: No- Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals at the end of the mating period.
- Maternal animals: All surviving animals - PND4 of the last of the parturition.
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera. Number of implantation sites in the uteri were recorded. In addition, the organs of males that failed to sire and females that were non-mated or non-pregnant in low- and mid-dose groups were also examined.
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues - testes and epididymus were weighed. - Statistics:
- Single factor analysis of variance and if there was significant difference, followed by Dunnett's test. The data from the clinical observations were validated by X2 test. The incidences of gross necroscopy and pathological findings were analysed by the unilateral Fischer's exact probability test.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- No deaths or clinical signs were observed in either the males or the solvent control.
300mg/kg bw
One rat was emaciated during lactation - dead PND6.
One rat had soiled perineal region during parturition and lactation dead PND4.
One rat has dehairing on prothorax.
800 mg/kg bw
One rat has dehairing on lower left abdomen.
No other clinical signs. - Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- Two females in the 300 mg/kg bw died PND4 and PND6. These deaths were not statistically significant compared to the solvent control
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- 800 mg/kg bw
The body weight before parturition (GD20) had a statistically significant decrease compared to control group (p ≤ 0.05) - Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- 1000 mg/kg bw
Mean food consumption for male rats in week 2 had a statistically significant decrease compared to the control group (p ≤ 0.05) but no significant difference was observed compared to the mean and total food consumption.
100/300 mg/kg bw
During the pre-mating period, the first week and total food consumption female rats had a statistically significant decrease compared to the control group (p ≤ 0.05) but no significant difference was observed comparing the mean and total food consumption (p>0.05). There was no significant difference in food consumption of pregnant rats during gestation and lactation in all dose groups compared with the solvent control (p>0.05).
The increase or decrease in food consumption had no dose dependent adverse effect, so it was considered that the results had no correlation with test item toxicity. - Organ weight findings including organ / body weight ratios:
- effects observed, non-treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
Reproductive function / performance (P0)
- Reproductive performance:
- no effects observed
Effect levels (P0)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 800 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- reproductive performance
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- reproductive performance
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- organ weights and organ / body weight ratios
- gross pathology
- histopathology: non-neoplastic
- Key result
- Dose descriptor:
- LOAEL
- Effect level:
- 800 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- organ weights and organ / body weight ratios
- gross pathology
- histopathology: non-neoplastic
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- organ weights and organ / body weight ratios
- gross pathology
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No malformation or abnormalities were observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- There was no significant difference in average litter weight in any dose group compared to the control (p>0.05)
Effect levels (F1)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 300 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: Developmental toxicity
- Key result
- Dose descriptor:
- LOAEL
- Generation:
- F1
- Effect level:
- 800 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: Developmental toxicity
Overall reproductive toxicity
- Reproductive effects observed:
- yes
- Lowest effective dose / conc.:
- 800 mg/kg bw/day
- Treatment related:
- yes
- Relation to other toxic effects:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Based on these results, it is concluded that the No Observed Adverse Effect Level (NOAEL) for general toxicity to males for exposure to Methyl Iodouracil is 1000mg/kg bw; the Lowest Observed Adverse Effect Level (LOAEL) for general toxicity to females for exposure to Methyl Iodouracil is 800mg/kg bw; the NOAEL for reproduction toxicity to males for oral exposure to Methyl Iodouracil is 1000mg/kg bw; the NOAEL for general toxicity to females for oral exposure to Methyl Iodouracil is 300mg/kg bw; the LOAEL for development exposure to pups to Methyl Iodouracil is 1000mg/kg bw
- Executive summary:
This study was conducted to provide initial information on possible effects on Reproduction/Development toxicity for Methyl Iodouracil following oral exposure in rats, and also to be used as a dose range finding study for other Reproduction/Development studies. This test was designed to be compatible with the Guidelines for the Testing of Chemicals (2nd Edition) No. 421 Reproduction/Development Toxicity Screening Test (2013).
The study was conducted in SD rats and all animals were SPF grade. Based on the results of the preliminary test for repeated dose oral toxicity, three doses of 1000, 300 and 100 mg/kg bw for males and 800, 300 and 100 mg/kg bw for females were used. A concurrent solvent control was included. There were fourteen male and fourteen female rats in each group. All animals were dosed during the two weeks prior to dosing, the two weeks of the mating period and up to the day before the scheduled kill. The test was terminated four days after the birth of the last litter pup. Clinical observations were made daily, and body weight and food consumption were weighed weekly. The Reproduction/Development parameters were evaluated at the same time. All parental animals were macroscopically examined for any abnormalities and pathological changes. A histopathology examination was carried out on the reproductive organs of rats in the control group and high dose group.
No deaths or clinical toxicity was observed in males in either the solvent control group or any dose groups. In the 300 mg/kg bw, female rat (No. 2205) was emaciated during the lactation period and died 6 days after parturition, a female rat (No. 2208) had soiled perineal region on the day of parturition and during the lactation period and died on the 4th day after parturition, a female rat (No 2213) had dehairing on the prothorax and a female rat (No 2307) had dehairing on the lower part of left abdomen.
No significant difference in body weight in males was found in any dose group compared to the solvent control group (p>0.05). The body weight of females in the high dose group had a significant decrease compared with the control group during parturition. No significant difference in food consumption between males and females was found in any dose group compared to the solvent control group.
The mated ratio and reproduction ratio of males in all dose groups had no significant difference compared with the solvent control group (p>0.005). The mated ratio, pregnancy ratio and live birth index of female in all dose groups had no significant difference compared with the solvent control group (p>0.005). There was no significant difference of mating time and gestation time in all dose groups compared with the solvent control group (p>0.005).No pregnant rats died from dystocia and none had all stillbirth pups. These results indicate that there was no adverse affect on the fertility of either males or females.
The loss of pups in the high-dose groups before and after birth had a statistically significant increase compared with the solvent control group (p<0.01). The live birth index had a statistically significant decrease (p<0.05) and all the pups in four litters were dead within four days of birth. The live birth index in low- and mid-dose had no statistically significant effect. The post implantation loss had no statistically significant increase and the viability index of birth had no statistically significant decrease. The males ratio of the low-dose group had a statistically significant increase compared to the control group (p≤0.05) but no significant differences were observed in mid- and high-dose groups (p>0.05). Therefore, the results were considered to have no toxicological significance.
There was no significant difference in average litter weight in all dose groups compared with the solvent control (p>0.05) in PND0 and PND4. All pups of animals 2306 and 2307 were puny compared to the solvent control group on the same birth day and died berfore PND4. No malformations or significant abnormalities in other live pups were observed from birth to study ending. The gross necroscopy and histopathological examinations carried out on the animals showed no significant difference related to to test item treatment.
Exposure of rats to various oral doses of Methyl Iodouracil resulted in no deaths. No clinical toxicity observations were made for males in either the solvent control group or any dose groups. Two females in the 300 mg/kg bw group died during the lactation period. Some females had dehairing in the 300 and 800 mg/kg bw groups but the death index and sympton incidence rate had no significant increase compared with the solvent control group and was not dose related, so this was not an adverse effect of the treatment of the test item. At the 800mg/kg bw dose rate, the body weights of females were adversely affected, so it can be concluded that Methyl Iodouracil had general toxicity to parental females at this dose level.
For Reproduction/Developmental, there was no adverse effects on the fertility of males in the 1000mg/kg bw group. There was no adverse effects on the fertility of females in the 800 mg/kg bw but the loss of pups before and after birth had a statistically significant increase. The growth of some pups were affected, so it is considered that Methyl Iodouracil had induced some effect on pups in the 800mg/kg bw, namely developmental toxicity.
Based on these results, it is concluded that the No Observed Adverse Effect Level (NOAEL) for general toxicity to males for exposure to Methyl Iodouracil is 1000mg/kg bw; the Lowest Observed Adverse Effect Level (LOAEL) for general toxicity to females for exposure to Methyl Iodouracil is 300mg/kg bw; the NOAEL for reproduction toxicity to males for oral exposure to Methyl Iodouracil is 1000mg/kg bw; the NOAEL for general toxicity to females for oral exposure to Methyl Iodouracil is 800mg/kg bw; the LOAEL for development exposure to pups to Methyl Iodouracil is 1000mg/kg bw;
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.